The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 27 Suppl 2, Issue , 2000, Pages 592-599

  Kohno, N ^a   Kitahara, S ^a   Tamura, E ^a   Tanabe, T ^a   Nakanoboh, M ^a   Kawada, M ^a   Shirasaka, T ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CF REGIMEN; CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ANEMIA; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; HEAD AND NECK TUMOR; HUMAN; MALE; MIDDLE AGED; MORTALITY; NAUSEA; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; SURVIVAL; TUMOR RECURRENCE; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NAUSEA; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; VOMITING, ANTICIPATORY;

EID: 0034181201     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)